Patents by Inventor Anjali Pathak

Anjali Pathak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nicotine receptor agonists in stem cell and progenitor cell recruitment
    Patent number: 8163780
    Abstract: The present invention features methods for recruitment of bone marrow-derived stem cells (e.g., endothelial cell precursors, hematopoietic stem cells) by administration of nicotine or other nicotine receptor agonist. The methods of the invention can be used in, for example, treatment of conditions amenable to treatment by recruitment of bone marrow-derived stem cells (e.g., neutropenia).
    Type: Grant
    Filed: November 16, 2010
    Date of Patent: April 24, 2012
    Assignee: The Board of Trustees of the Leland Stanford Jr. University
    Inventors: John Cooke, Frances Lauri Johnson, Anjali Pathak, James Jang, Philip Tsao, Christopher Heeschen
  • NICOTINE RECEPTOR AGONISTS IN STEM CELL AND PROGENITOR CELL RECRUITMENT
    Publication number: 20110124688
    Abstract: The present invention features methods for recruitment of bone marrow-derived stem cells (e.g., endothelial cell precursors, hematopoietic stem cells) by administration of nicotine or other nicotine receptor agonist. The methods of the invention can be used in, for example, treatment of conditions amenable to treatment by recruitment of bone marrow-derived stem cells (e.g., neutropenia).
    Type: Application
    Filed: November 16, 2010
    Publication date: May 26, 2011
    Inventors: John Cooke, Frances Lauri Johnson, Anjali Pathak, James Jang, Philip Tsao, Christopher Heeschen
  • Nicotine receptor agonists in stem cell and progenitor cell recruitment
    Patent number: 7838539
    Abstract: The present invention features methods for recruitment of bone marrow-derived stem cells (e.g., endothelial cell precursors, hematopoietic stem cells) by administration of nicotine or other nicotine receptor agonist. The methods of the invention can be used in, for example, treatment of conditions amenable to treatment by recruitment of bone marrow-derived stem cells (e.g., neutropenia).
    Type: Grant
    Filed: February 13, 2004
    Date of Patent: November 23, 2010
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: John Cooke, Frances Lauri Johnson, Anjali Pathak, James Jang, Philip Tsao, Christopher Heeschen
  • Nicotine receptor agonists in stem cell and progenitor cell recruitment
    Publication number: 20050038079
    Abstract: The present invention features methods for recruitment of bone marrow-derived stem cells (e.g., endothelial cell precursors, hematopoietic stem cells) by administration of nicotine or other nicotine receptor agonist. The methods of the invention can be used in, for example, treatment of conditions amenable to treatment by recruitment of bone marrow-derived stem cells (e.g., neutropenia).
    Type: Application
    Filed: February 13, 2004
    Publication date: February 17, 2005
    Inventors: John Cooke, Frances Johnson, Anjali Pathak, James Jang, Philip Tsao, Christopher Heeschen
  • Nicotine receptor agonists in stem cell and progenitor cell recruitment
    Patent number: 6720340
    Abstract: The present invention features methods for recruitment of bone marrow-derived stem cells (e.g., endothelial cell precursors, hematopoietic stem cells) by administration of nicotine or other nicotine receptor agonist. The methods of the invention can be used in, for example, treatment of conditions amenable to treatment by recruitment of bone marrow-derived stem cells (e.g., neutropenia).
    Type: Grant
    Filed: July 28, 2000
    Date of Patent: April 13, 2004
    Assignee: The Board of Trustees of the Leland Stanford, Jr. Unversity
    Inventors: John Cooke, Frances Lauri Johnson, Anjali Pathak, James Jang, Phillip Tsao, Christopher Heeschen